Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport

scientific article

Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1124/DMD.108.026286
P698PubMed publication ID19220984
P5875ResearchGate publication ID24019087

P2093author name stringTao Zhang
David C Gale
Jingjing Ye
Chunze Li
Ellen Y Wu
Sue Zhou
Eric Y Zhang
Cathie D Xiang
Minerva Batugo
P433issue5
P304page(s)992-998
P577publication date2009-02-12
P1433published inDrug Metabolism and DispositionQ1261140
P1476titleCharacterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport
P478volume37

Reverse relations

cites work (P2860)
Q98895679Amantadine can induce intra-epithelial deposition in the cornea
Q39171184Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines
Q54219035Characterization of monocarboxylate uptake and immunohistochemical demonstration of monocarboxylate transporters in cultured rabbit corneal epithelial cells.
Q39492528Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells
Q53527063Design and development of an in vitro tear replenishment system.
Q35170366Development of a curved, stratified, in vitro model to assess ocular biocompatibility
Q28542904Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models
Q45073331Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery.
Q38695101In vitro and ex vivo corneal penetration and absorption models.
Q37850457In vitro cell culture models to study the corneal drug absorption
Q40500118Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters
Q39760193Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea
Q37682926Multifunctional organic-inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery
Q51122641Ocular Drug Delivery.
Q30475605Ocular drug delivery
Q35187905Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow
Q39273066Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier
Q41891370Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically
Q42031044Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor
Q35950189Prodrug approach to improve absorption of prednisolone
Q38913947Upregulation of P-glycoprotein expression by ophthalmic drugs in different corneal in-vitro models
Q35990861mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs

Search more.